Condition: Asthma
Interventions: Other: caffeine; Other: No caffeine
Sponsor: University of Saskatchewan
Completed – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Other: caffeine; Other: No caffeine
Sponsor: University of Saskatchewan
Completed – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Conditions: Bronchial Asthma; Nitric Oxide
Intervention:
Sponsor: Mahidol University
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.
7thSpace Interactive (press release) Airway eosinophilia is considered a central event in the pathogenesis of asthma. Eotaxin plays a key role in selective eosinophil accumulation in the … |
View full post on asthma – Google News